FHL2 and osteosarcoma: The knockdown of FOXK1 resulted in decreased cell proliferation rates and the development of the malignant phenotype in human osteosarcoma U2OS cells.33 The data indicate that the synergistic overexpression of FHL2 and FOXK1 enhanced cell growth.